Late onset of de novo atypical hemolytic-uremic syndrome presented on a simultaneous pancreas and kidney transplant recipient successfully treated with eculizumab

Nefrologia. 2016 May-Jun;36(3):328-9. doi: 10.1016/j.nefro.2016.02.003. Epub 2016 Mar 21.

[Article in English, Spanish]

Authors

Francisco Javier Juega-Mariño¹, Neus Sala², Dolores López³, Laura Cañas², Josep Bonet², Ricardo Lauzurica²

Affiliations

¹ Servicio de Nefrología, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain. Electronic address: juega.javier@gmail.com.
² Servicio de Nefrología, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
³ Servicio de Anatomía patológica, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.

PMID: 27012439
DOI: 10.1016/j.nefro.2016.02.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Atypical Hemolytic Uremic Syndrome / drug therapy
Atypical Hemolytic Uremic Syndrome / etiology*
Diabetes Mellitus, Type 1 / surgery*
Female
Humans
Immunosuppressive Agents / therapeutic use
Kidney Transplantation*
Middle Aged
Pancreas Transplantation*
Postoperative Complications / drug therapy
Postoperative Complications / etiology*
Time Factors

Substances

Antibodies, Monoclonal, Humanized
Immunosuppressive Agents
eculizumab